PatternsRadar
Sign in

SGRLSGRL

NSE
605.75INR-10.30 (-1.67%)Close · 20 Nov 2026
—Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹777 CrMarket cap
—P/E (TTM)
80.7%Delivery

Growth

Revenue YoY—
Profit YoY—
Interest cost YoY—
Revenue QoQ—
Profit QoQ—
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

Open617.30
Day range605.00 – 623.00
52-week range—
From 52w high—
RSI (14)42.5
ATR (14)32.65
Volume8.3K
Avg volume (20D)9.1K
Rel volume0.91×
Volatility (1Y)57.6%
Turnover₹50.8L
Traded value (NSE)₹50.8L
VWAP612.86
SMA 50 / 200659.48 / —
Price band20%

Delivery percentage

Latest · 20 Nov 202680.7%
20-day avg66.4%
1-year avg62.9%
Percentile (own history)99th
Range41.4–80.9%
Sessions67

Over the last 20 sessions SGRL settled 66.4% of its traded quantity, which is unusually high for an NSE equity. Its one-year average is 62.9%, so recent sessions are running 3.5 points higher than usual.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders—
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buynever

Performance returns

1D1W1M3M6M1Y
Price-1.67%-7.93%-7.50%+20.90%——

Valuation

Market cap₹777 Cr
Market cap (NSE)₹777 Cr
Free-float cap—
P/E (TTM)—
EPS (TTM)—
P/B—
Net margin (TTM)—
Other income / PBT—
ROE—
Debt / equity—
Shares outstanding—
Listed17 Aug 2026

Ownership

Promoter—
Promoter Δ QoQ—
Public—
FII—
DII—
Pledged—

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Price-band hits

Loading…

Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.

Short selling, lending & margin

Loading…

Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to SGRL.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures.

Every stock on this session →

SGRL at a glance

  • SGRL closed at ₹605.75 on 20 Nov 2026, -1.67% on the day.
  • Delivery was 80.7% of traded quantity on 20 Nov 2026, the 99th percentile of its own 67 sessions with a reading (20-session average 66.4%, 1-year average 62.9%).
  • Market capitalisation is ₹777 crore, with no positive trailing earnings for a P/E.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE414Y01015
SeriesEQ
Listed17 Aug 2026
NSE market cap · 17 Nov 2026₹791 Cr
Free-float market cap (NSE)₹215 Cr
Shares outstanding (NSE)1.28Cr
History from17 Aug 2026
Sessions67

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.